Molecular Mechanism of Terbinafine Resistance in Saccharomycescerevisiae
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Ten mutants of the yeast Saccharomyces cerevisiae resistant to the antimycotic terbinafine were isolated after chemical or UV mutagenesis. Molecular analysis of these mutants revealed single base pair exchanges in the ERG1 gene coding for squalene epoxidase, the target of terbinafine. The mutants did not show cross-resistance to any of the substrates of various pleiotropic drug resistance efflux pumps tested. The ERG1 mRNA levels in the mutants did not differ from those in the wild-type parent strains. Terbinafine resistance was transmitted with the mutated alleles in gene replacement experiments, proving that single amino acid substitutions in the Erg1 protein were sufficient to confer the resistance phenotype. The amino acid changes caused by the point mutations were clustered in two regions of the Erg1 protein. Seven mutants carried the amino acid substitutions F 402 L (one mutant), F 420 L (one mutant), and P 430 S (five mutants) in the C-terminal part of the protein; and three mutants carried an L 251 F exchange in the central part of the protein. Interestingly, all exchanges identified involved amino acids which are conserved in the squalene epoxidases of yeasts and mammals. Two mutations that were generated by PCR mutagenesis of the ERG1 gene and that conferred terbinafine resistance mapped in the same regions of the Erg1 protein, with one resulting in an L 251 F exchange and the other resulting in an F 433 S exchange. The results strongly indicate that these regions are responsible for the interaction of yeast squalene epoxidase with terbinafine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353
Sanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 2×
“This type of resistance is mediated by overexpression of transporters belonging to either the major facilitator superfamily (MFS) or the ATP binding cassette (ABC) transporter superfamily (27, 40, 42).”
BackgroundPerea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · cited 2×
“Elevated levels of ERG11 mRNA were found in several azole-resistant clinical isolates of C. albicans and C. glabrata, suggesting that the amount of lanosterol 14-demethylase (Erg11p) is higher and contributes to azole resistance in the isolates (8, 26, 28, 32 ).”
BackgroundFranz, R., Kelly, S. L., Lamb, D. C., Kelly, D. E., Ruhnke, M., & Morschhäuser, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3065 · Cited by 339 · cited 1×
“Since multiple mechanisms can lead to drug resistance and often contribute simultaneously to the development of highlevel resistance after long-term treatment with antimycotics (8, 46), we had to consider the potential involvement of additional mechanisms in the terbinafine resistance phenotypes of our mutants.”
BackgroundMolecular biological characterization of an azole-resistant Candida glabrata isolate
Marichal, P., Vanden Bossche, H., Odds, F. C., Nobels, G., Warnock, D. W., Timmerman, V, Van Broeckhoven, C., Fay, S., & Mose-Larsen, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2229 · Cited by 210 · cited 1×
“Elevated levels of ERG11 mRNA were found in several azole-resistant clinical isolates of C. albicans and C. glabrata, suggesting that the amount of lanosterol 14-demethylase (Erg11p) is higher and contributes to azole resistance in the isolates (8, 26 , 28, 32).”
BackgroundMarr, K. A., Lyons, C. N., Rustad, T., Bowden, R. A., & White, T. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.10.2584 · Cited by 166 · cited 4×
“This type of resistance is mediated by overexpression of transporters belonging to either the major facilitator superfamily (MFS) or the ATP binding cassette (ABC) transporter superfamily (27, 40, 42).”
BackgroundResultInfluentialKelly, S. L., Lamb, D. C., Loeffler, J., Einsele, H., & Kelly, D. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1136 · Cited by 116 · cited 2×
“Despite the high selectivity of azole inhibition, many amino acid substitutions affected positions that are conserved in fungal and mammalian demethylases (7, 15 , 19, 20, 39).”
BackgroundMolecular genetic analysis of azole antifungal mode of action
Kelly, S. L., Arnoldi, A., & Kelly, D. E. (1993) · Biochemical Society Transactions · doi:10.1042/bst0211034 · Cited by 106
Cited by
Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis
Scorzoni, L., de Paula e Silva, A. C. A., Marcos, C. M., Assato, P. A., de Melo, W. C. M. A., de Oliveira, H. C., Costa-Orlandi, C. B., Mendes-Giannini, M. J. S., & Fusco-Almeida, A. M. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2017.00036 · Cited by 418
“Ergosterol is a lipid responsible for membrane fluidity and permeability and for the function of fungal integral membrane proteins; accordingly, this sterol is essential for cell viability (Leber et al., 2003; Tatsumi et al., 2013; Song et al., 2016).”
BackgroundYamada, T., Maeda, M., Alshahni, M. M., Tanaka, R., Yaguchi, T., Bontems, O., Salamin, K., Fratti, M., & Monod, M. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00115-17 · Cited by 343
An update on antifungal targets and mechanisms of resistance in Candidaalbicans
Akins, R. A. (2005) · Medical Mycology · doi:10.1080/13693780500138971 · Cited by 291
Rudramurthy, S. M., Shankarnarayan, S. A., Dogra, S., Shaw, D., Mushtaq, K., Paul, R. A., Narang, T., & Chakrabarti, A. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02522-17 · Cited by 273
Survival in the Presence of Antifungals
Meyer, V., Damveld, R. A., Arentshorst, M., Stahl, U., van den Hondel, C. A. M. J. J., & Ram, A. F. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705856200 · Cited by 85
Metadata
- Authors
- Leber, R., Fuchsbichler, S., Klobučníková, V., Schweighofer, N., Pitters, E., Wohlfarter, K., Lederer, M., Landl, K., Ruckenstuhl, C., Hapala, I., & Turnowsky, F.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2003-12
- Volume
- 47
- Issue
- 12
- Pages
- 3890-3900
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W1972264170
- Cited by
- 69
- References
- 8
- FWCI
- 3.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Molecular Mechanism of Terbinafine Resistance in Saccharomycescerevisiae. https://app.cochat.ai/papers/10.1128/aac.47.12.3890-3900.2003
- The paper
- Leber, R., Fuchsbichler, S., Klobučníková, V., Schweighofer, N., Pitters, E., Wohlfarter, K., Lederer, M., Landl, K., Ruckenstuhl, C., Hapala, I., & Turnowsky, F. (2003). Molecular Mechanism of Terbinafine Resistance in Saccharomycescerevisiae. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.47.12.3890-3900.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.